Mumbai: Global pharma major Lupin Limited (Lupin) today announced that it has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug ...
Canada is the first G7 country to approve the lower cost weight-loss drugs, which are rolling out in pharmacies this month.
NATCO Pharma announced that its alliance partner, Lupin, has received approval from the United States Food and Drug Administration (USFDA) for NATCO's abbreviated new drug application (ANDA) for ...
Lupin advanced 1.68% to Rs 2,286.50 after the company announced that the United States Food and Drug Administration (USFDA) has approved its ranibizumab, Ranluspec (ranibizumab-hkdz) injection.
The MarketWatch News Department was not involved in the creation of this content. MIRAMAR, Fla., Feb. 12, 2026 /PRNewswire/ -- DifGen Pharmaceuticals, a leading US based generic pharmaceutical company ...
Bionpharma Inc. Receives USFDA Approval for Etravirine Tablets Developed in Collaboration with STEERLife PR Newswire NEW YORK and BENGALURU, India, Jan. 13, 2026 Jointly developed HIV-1 therapy ...
With global pharmaceutical companies heading into a major patent expiry cycle over the next decade, pharma major Lupin is increasing its focus on complex generics, biosimilars and specialty medicines ...
The US Food and Drug Administration (FDA) just launched a new webpage to share recent actions and activities related to complex generic drugs to spur their development. “Since these products are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results